Gene · 7532
Papers1,458
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,458
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| YWHAG overexpression correlates with an immune-desert microenvironment and poor prognosis in laryngeal squamous cell carcinoma. | Front Immunol | 2026 | 42812507 | PubTator, text mining | PubMed |
| Transient ultrastructural remodeling of the open canalicular system and α-granules is associated with endothelial responses after BNT162b2 vaccination in healthy volunteers. | Biomed Pharmacother | 2026 | 42809927 | PubTator, text mining | PubMed |
| Identification of Inflammatory Cell Death-Related Prognostic Signature and Its Regulatory Mechanism in Lung Adenocarcinoma. | Cancer Med | 2026 | 42760759 | PubTator, text mining | PubMed |
| Stratifying lung adenocarcinoma: a novel prognostic model based on mitochondrial outer membrane permeabilization activity. | 3 Biotech | 2026 | 42745950 | PubTator, text mining | PubMed |
| Isoform-resolved 14-3-3/YWHA networks in colorectal cancer: phospho-adaptor mechanisms, biomarker contexts and therapeutic opportunities. | Front Oncol | 2026 | 42688965 | PubTator, text mining | PubMed |
| Integrated PANoptosis Profiling Identifies Immunosuppressive Subtypes and a Prognostic Signature With Functional Validation of MLKL in Glioblastoma. | Ann Clin Transl Neurol | 2026 | 42421178 | PubTator, text mining | PubMed |
| Decoding The Epitranscriptome: In Silico Insights Into m6A Regulatory Network In Breast Cancer. | J Vis Exp | 2026 | 42372047 | PubTator, text mining | PubMed |
| Beyond amyloid and tau: synaptic and neurodegenerative biomarkers shape MCI progression. | Mol Psychiatry | 2026 | 42337011 | PubTator, text mining | PubMed |
| A P-body-related risk score predicts prognosis and immune microenvironment in lung adenocarcinoma. | Transl Cancer Res | 2026 | 42305460 | PubTator, text mining | PubMed |
| From prediction to mechanism: Explainable AI uncovers plasma and CSF proteomic signatures of Alzheimer's disease. | J Proteomics | 2026 | 42297098 | PubTator, text mining | PubMed |
| YWHAG as a novel biomarker in Alzheimer's disease biological research framework. | J Alzheimers Dis | 2026 | 42179099 | PubTator, text mining | PubMed |
| A single large-scale mitochondrial DNA deletion presenting as rapidly progressive dementia in a 35-year-old male. | NPJ Dement | 2026 | 42058635 | PubTator, text mining | PubMed |
| Astrocyte-related proteins mediate the association of YWHAG with Alzheimer's pathology and enhance its diagnostic value. | Transl Psychiatry | 2026 | 41957344 | PubTator, text mining | PubMed |
| Identification of plasma exosome circRNA as potential novel biomarkers for DLBCL and circrna-miRNA-mRNA network analysis. | Clin Exp Med | 2026 | 41925757 | PubTator, text mining | PubMed |
| Deleterious coding variation associated with autism is shared across ancestries. | Nat Med | 2026 | 41912808 | PubTator, text mining | PubMed |
| 14-3-3γ Knockdown promotes matrix mineralization in human mesenchymal stromal cells. | Cell Death Dis | 2026 | 41896518 | PubTator, text mining | PubMed |
| Natural History of YWHAG-Associated Neurodevelopmental Disorder. | Pediatr Neurol | 2026 | 41886798 | PubTator, text mining | PubMed |
| Identification of 14-3-3 Proteins as Binding Partners of TRP Channels. | J Chem Inf Model | 2026 | 41839059 | PubTator, text mining | PubMed |
| Proteomic Analysis of Cerebrospinal Fluid from Severe COVID-19 Patients Reveals Prognostic Biomarkers Associated with Disease Outcome. | Proteomics Clin Appl | 2026 | 41830303 | PubTator, text mining | PubMed |
| Differentially expressed proteins in plasma-derived extracellular vesicles from chronic myeloid leukemia patients. | Front Genet | 2026 | 41773228 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7532/papers